Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 686-693

  Fox, Anthony W ^a   Sullivan, Brian W ^a   Buffini, Joan D ^a   Neichin, Maura L ^b   Nicora, Robert ^b   Hoehler, Fred K ^b   O'Rourke, Randal ^c   Stoltz, Randall R ^d  

^a Cypros Pharmaceutical Corporation   (United States)

^b S Diego Clin Research Associates   (United States)

^c Wisconsin Analyt and Res Services   (United States)

^d GFI Pharmaceutical Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLOROACETIC ACID; LACTIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; SOMNOLENCE;

AGED; DICHLOROACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MODELS, BIOLOGICAL;

EID: 0030437931     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. ABEMAYOR, E., KOVACHICH, G. B. AND HAUGAARD, N.: Effects of dichloroacetate on brain pyruvate dehydrogenase. J. Neurochem. 42: 38-42, 1984.
2. BARSAN, W. G., HEDGES, J. R., SYVERUD, S. A., DRONEN, S. C. AND DIMLICH, R. V. W.: Effects of dichloroacetate in spinal stroke in the rabbit. Life Sci. 41: 1065-1069, 1987.
3. BAUDRY, M., KESSLER, M., SMITH, E. K. AND LYNCH, G.: The regulation of pyruvate dehydrogenase activity in rat hippocampal slices: Effect of dichloroacetate. Neurosci. Lett. 31: 41-46, 1982.
4. BIROS, M. H., DIMLICH, R. V. AND BARSAN, W. G.: Post-insult treatment of ischemia-induced cerebral lactic acidosis in the rat. Ann. Emerg. Med. 15: 397-404, 1986.
5. CARRARO, F., KLEIN, S., ROSENBLATT, J. I. AND WOLFE, R.: Effect of dichloroacetate on lactate concentration in exercising humans. J. Appl. Physiol. 66: 591-597, 1989.
6. CHANG, L.-H., SHIMIZU, H., ABIKO, H., SWANSON, R. A., FADEN, A. I., JAMES, T. L. AND WEINSTEIN, P. R.: Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats. J. Cerebr. Blood Flow Metab. 12: 1030-1038, 1992.
7. COLBURN, W. A.: Combined pharmacokinetic/pharmacodynamic (PK/PD) modeling. J. Clin. Pharmacol. 28: 769-771, 1988.
8. COLOHAN, A. R., WELSH, F. A., MILLER, E. D. AND KASSELL, N. F.: The effect of dichloroacetate on brain lactate levels following incomplete ischemia in the hyperglycemic rat. Stroke 17: 525-528, 1986.
9. COUDE, F. X., SAUDUBRAY, J. M., DE MAUGRE, F., MARSAC, C., LEROUX, J. P. AND CHARPENTIER, C.: Dichloroacetate as treatment for congenital lactic acidosis. New Eng. J. Med. 299: 1365-1366, 1978.
10. CURRY, S. H., CHU, P., BAUMGASTNER, T. G. AND STACPOOLE, P. W.: Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin. Pharmacol. Ther. 37: 89-93, 1985.
11. CURRY, S. H., LORENZ, A., CHU, P. I., LIMACHER, M. AND STACPOOLE, P. W.: Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug Disp. 12: 375-390, 1991a.
12. CURRY, S. H., LORENZ, A., HENDERSON, G. N., MARS, D. R. AND STACPOOLE, P. W.: Haemodialysis studies with dichloroacetate. Eur. J. Clin. Pharmacol. 40: 613-617, 1991b.
13. DAYNEKA, N. L., GARG, V. AND JUSKO, W. J.: Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm. 21: 457-478, 1993.
14. DE STEFANO, N., MATTHEWS, P. M., FORD, B., GENOE, A., KARPATI, G. AND ARNOLD, D. L.: Short term dichloroacetate improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45: 1193-1198, 1995.
15. DIMLICH, R. V. AND NIELSON, M. M.: Facilitating post-ischemic reduction of cerebral lactate in rats. Stroke 17: 525-528, 1992.
16. DIMLICH, R. V. W., TIMERDING, B. L., KAPLAN, J., CAMMENGA, R. AND VAN LIGTEN, P. F.: Brain metabolites associated with cerebral ischemia. Ann. Emerg. Med. 18: 1172-1180, 1989.
17. ESPINAL, J., LEESNITZER, T., HASSMAN, A., BEGGS, M. AND COBB, J.: Inhibition of pyruvate dehydrogenase by halogenated acetophenones. Drug Dev. Res. 36: 130-136, 1995.
18. EVANS, O. B.: Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation. Biochem. Pharmacol. 31: 3124-3126, 1982.
19. FOX, A. W., KARAPANOS, G. AND MITCH, W. E.: Non-competitive antagonism of vascular vasopressin, receptors. J. Pharmacol. Exp. Ther. 243: 598-602, 1987.
20. HAWKINS, R. D. AND KALANT, H.: The metabolism of ethanol and its metabolic effects. Pharmacol. Rev. 24: 242-249, 1972.
21. JUSKO, W. J. AND KO, H. C.: Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin. Pharmacol. Ther. 56: 406-419, 1994.
22. KALIMO, H.: Brain lactic acidosis and ischemic cell damage: 2. Histopathology. J. Cerebr. Blood Flow & Metab. 1: 313-327, 1981.
23. KODAMA, H., YAMAGUCHI, S., OKABE, I., KODAMA, M., ORII, T. AND KAMOSHITA, S.: Renal effects of dichloroacetate in vivo. Clin. Chim. Acta 160: 265-271, 1986.
24. KRISHNA, S., AGBENYEGA, T., ANGUS, B. J., BEDU-ADDO, G., OFORI-AMANFO, G., HENDERSON, G., SZWANDT, I. S. F., O'BRIEN, R. AND STACPOOLE, P. W.: Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q. J. Med. 88: 341-349, 1995.
25. KURODA, V., TOSHIMA, K., WATANABE, T., KOBASHI, H., ITO, M., TAKEDA, E. AND MIYAO, M.: Effects of dichloroacetate on pyruvate metabolism in rat brain in vivo. Pediatr. Res. 18: 936-938, 1984.
26. KURODA, Y., ITO, M., TOSHIMA, K., TAKEDA, E., NAITO, E., HWANG, T. J., HASIMOTO, T., MIYAO, M., MASUDA, M., YAMASHITA, K., ADACHI, T., SUZUKI, Y. AND NISHIYAMA, K: Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J. Inner. Metab. Dis. 9: 244-252, 1986.
27. LEE, J. W., HULSE, J. D. AND COLBURN, W. A.: Surrogate biochemical markers: Precise measurement for strategic drug and biologies development. J. Clin. Pharmacol. 35: 464-470, 1995.
28. LEMAY, D. R.: Neurological protection by dichloroacetate depending on the severity of injury in the paraplegic rat. J. Neurosurg. 73: 118-122, 1990.
29. LEWANDOWSKI, E. D. AND WHITE, E. T.: Pyruvate dehydrogenase influences post-ischemic heart function. Circulation 91: 2071-2079, 1995.
30. LIU, B., CLANACHAN, A. S., SCHULZ, R. AND LOPASCHUK, G. D.: Cardiac efficiency is improved following ischemia by altering both the source and fate of protons. Circulation, in press, 1996.
31. LOPASCHUK, G. D., WAMBOLT, R. B. AND BARR, R. L.: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J. Pharmacol. Exp. Ther. 264: 135-144, 1993.
32. LUDVIK, B., MAYER, G., STIFTER, S., PUTZ, D., BARNAS, U. AND GRAF, H.: Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch. 423: 251-254, 1993.
33. LUTZ, M. W., MORGAN, P. H., JAMES, M. K., FELDMAN, P. L., BRACKEEN, M. F., LAHEY, A. P., JAMES, S. V., BILOTTA, J. M. AND PRESSLEY, J. C.: A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics. J. Pharmacol. Exp. Ther. 271: 795-803, 1994.
34. LUKAS, G., KUNJABA, H. V., BRINDLE, S. D., LE SHER, A. R. AND WAGNER, W. E.: Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration. J. Pharmaceut. Sci. 69: 419-421, 1980.
35. MCVEIGH, J. J. AND LOPASCHUK, G. D.: Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am. J. Physiol. 259: H1079-H1085, 1990.
36. 1 adrenoceptors and contraction of rat vas deferens. Mol. Pharmacol. 23; 359-368, 1983.
37. OKABE, I.: Treatment of lactic acidosis: Effects of dichloroacetate on lactate and pyruvate levels in the cerebrospinal fluid. Eur. J. Pediatr. 145: 159, 1986.
38. ROBERTSON, C. S.: Reduction in spinal cord post-ischemic lactic acidosis and functional improvement with dichloroacetate. J. Neurotrauma 7: 1-12, 1990.
39. SHANGRAW, R. E. AND FISHER, D. M.: Pharmacokinetics of dichloroacetate in patients undergoing liver transplantation. Anesthesiology 84: 851-858, 1996.
40. SHEINER, L. B., STANSKI, D. R., VOZEH, S., MILLER, R. D. AND HAM, J.: Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 25: 358-371, 1979.
41. STACPOOLE, P. W.: The pharmacology of dichloroacetate. Metabolism (Clin. & Exp.) 38: 1124-1144, 1989.
42. STACPOOLE, P. W., WRIGHT, E. C. AND BAUMGARTNER, T. G. FOR THE DICHLOROACETATE-LACTIC ACIDOSIS STUDY GROUP: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. New Eng. J. Med. 327: 1564-1569, 1992.
43. STACPOOLE, P. W., HARMAN, E. M., CURRY, S. H., BAUMGARTNER, T. G. AND MISBIN, R. I.: Treatment of lactic acidosis with dichloroacetate. New Eng. J. Med. 309: 390-396, 1983.
44. STACPOOLE, P. W., LORENZ, A. C., THOMAS, R. G. AND HARMAN, E. M.: Dichloroacetate in the treatment of lactic acidosis. Ann. Intern. Med. 108: 58-63, 1988.
45. TOMSIG, J. L., GRUENSTEIN, E. AND DIMLICH, R. V. W.: Inhibition of lactate induced swelling by dichloroacetate in human astrocytoma cells. Brain Res. 568: 92-100, 1991.
46. WELLS, P. G., MOORE, G. W., RABIN, D., WILKINSON, G. R., OATES, J. A. AND STACPOOLE, P. W.: Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia 19: 109-113, 1980.
47. WHITEHOUSE, S., COOPER, R. H. AND RANDLE, P. J.: Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem. J. 141: 761-774, 1974.
48. WHITEHOUSE, S. AND RANDLE, P. J.: Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate. Biochem. J. 134: 651-653, 1973.